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Objective: We report our experience in the treatment of ureteral calculi by ureteroscopic stone manip-
ulation (URS-SM).
Materials and methods: In 2009, 420 patients with ureteral calculi underwent a total number of 438
URS-SMs with a lithoclast, holmium laser, or both. All patients were evaluated by plain radiography,
sonography, and excretory urography prior to the operation. Follow-up studies included plain ﬁlm and
sonography that were done immediately and 2 weeks after the operation.
Results: The overall stone-free rate was 95.4%. According to the location of the stones, respective success
rates for upper, middle, and lower ureteral stones were 88.4%, 97%, and 100%. The most common cause of
failure was stone migration (4.5%).
Conclusion: Ureteroscopic lithotripsy is a trustworthy procedure for treating ureteral calculi of different
sizes at all levels, and it can be efﬁcaciously and safely performed in expert hands.
Copyright  2012, Taiwan Urological Association. Published by Elsevier Taiwan LLC.
Open access under CC BY-NC-ND license.1. Introduction
Urologic management of urinary calculi has immensely changed
in the past 30 years. Various endourological treatment modalities
are available for urinary calculi including extracorporeal shock
wave lithotripsy (ESWL), ureteroscopic stone manipulation (URS-
SM), percutaneous nephrolithotomy, and laparoscopic lithotomy.
Although the majority of ureteral calculi can be efﬁciently treated
by ESWL, a substantial number of such calculi still require an
invasive approach. URS-SM of ureteral calculi is indicated for
failed ESWL, steinstrasse after ESWL, larger stone sizes, radiolucent
stones, and lower ureteral stones. In recent years, the advent of
smaller-caliber semirigid ureteroscopes (4.5 and 6 Fr) and advances
in efﬁcient intracorporeal lithotriptors such as the lithoclast and
holmium laser have resulted in high success and low morbidity
rates.1 In this report, we present our results in managing ureteral
calculi by semirigid ureteroscopy.
2. Materials and methods
From January to December in 2009, 420 patients with ureteral
calculi underwent URS-SM. The procedure was performed by any
one of the three urologists in our hospital (Tainan Municipal
Hospital, Tainan, Taiwan). Patients’ medical records were reviewedan Municipal Hospital, 670
.
ciation. Published by Elsevier Taiwwith the permission of the Institutional Research Ethics Board. In
these patients, 402 were unilateral stones and 18 were bilateral
stones. In total, 438 sessions were enrolled in the retrospective
analysis. There were 322 men and 98 women (ratio: 3.3:1) with
amean age of 49.7 (range,19w89) years. Patient characteristics and
stone locations are detailed in Table 1. URS-SM for failed ESWL was
performed in 132 patients (31.4%), including 64 in the upper ureter
(15.2%), 18 in the middle ureter (4.3%), and 50 in the lower ureter
(11.9%). Furthermore, steinstrasse after ESWL occurred in three
patients. Three patients (0.7%) underwent a percutaneous neph-
rostomy prior to the operation due to pyonephrosis or hydroureter
with tortuosity. Outpatient surgery was performed in 15 patients.
The mean hospital stay was 1.6 (range, 1w5) days.
Preoperative routine biochemical analysis, blood count, urinal-
ysis, and/or urine cultures were performed on all patients. Urinary
tract infections were preoperatively treated. Prophylactic antibi-
otics were intravenously injected in all patients. A plain abdominal
ﬁlm [kidneys, ureter, and bladder (KUB)], intravenous urography,
and sonography were performed before surgery, and postoperative
follow-up included KUB and sonography to evaluate the stone-free
status of patients; these were performed immediately and 2 weeks
postoperatively. Success was deﬁned as symptom relief, no
hydronephrosis on sonography, and a stone-free status or asymp-
tomatic residual fragments of  3 mm in diameter on KUB 2 weeks
after URS-SM.
Ureteroscopic stone disintegration, removal, or both were per-
formed using 4.5- and/or 6-Fr (RichardWolf, Knittlingen, Germany)
semirigid ureteroscopes with a pneumatic lithotriptor (Swissan LLC. Open access under CC BY-NC-ND license.
Table 1
Patient characteristics and stone location.
Upper
ureter
(n¼ 138)
Middle
ureter
(n¼ 33)
Lower
ureter
(n¼ 259)
Multiple and
steinstrasse
(n¼ 8)
Total
(n¼ 438)
Failed ESWL (no) 64 18 50 132
Double-J stent (no) 137 32 203 8 380
Hospital stay (d)
Mean standard
deviation
1.7 0.7 1.5 0.6 1.5 0.6 1.5 0.5 1.6 0.6
Range 1-5 1-3 1-4 1-2 1-5
Outpatient
surgery (no)
1 1 11 2 15
ESWL¼ extracorporeal shock wave lithotripsy.
Table 3
Complications of URS-SM.
Adverse event Patients, n (%)
Postoperative fever (> 38.5 C) 3 (0.7%)
Hematuria with blood clot retention 1 (0.2%)
Double-J upward migration 1 (0.2%)
Total 5 (1.1%)
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mium:YAG laser (Auriga; WaveLight 30 W, Interkardio, New Delhi,
India) under masked general anesthesia. We used the lithoclast
with two probes (0.8 mm and 1 mm) and a low-power holmium
laser with a 600-mm ﬁber at 800 or 1200 mJ and an 8-Hz pulse rate.
The majority of fragmented stones were left in situ for spontaneous
passage, while relatively large stone fragments were removed with
stone forceps. A ureteral catheter (3 or 4 Fr) or double-J stent (4.7 or
6 Fr) was placed in case of ureteral edema secondary to an impacted
stone, ureteral injury, impaired renal function, big stone burden, or
upward migration of stone fragments. The ureteral catheter or
double-J stent was removed a few hours to 2 weeks after surgery.
Additional ESWL combined with secondary URS-SM was applied
postoperatively for upwardly migrating stone fragments.
3. Results
According to the location of the stones, success rates of 430 total
one-session URS-SM for upper, middle, and lower ureteral stones
were 88.4%, 97.0%, and 100.0%, respectively. In addition, ﬁve of the
eight patients with unilateral multiple stone locations including
steinstrasse achieved a success rate of 62.5%. The overall success
rate after one session of URS-SM was 95.4% (418 of 438). These
results are summarized in Table 2. Stone migration into the kidney,
which occurred in 19 patients with stones located in the upper
ureter and one with a stone located in the middle ureter, was the
only cause of failure. Of 20 patients (4.6%) who required additional
ESWL for an upwardly migrating stone, 17 patients underwent one
session of ESWL plus one secondary URS-SM, and three required
two sessions of ESWL plus one secondary URS-SM; however, two of
these cases were lost to follow-up. Ultimately, the total stone
clearance rate was 100% (436 of 436). The rate of double-J stent
placement was 86.8% (380 of 438). Table 3 shows complications of
URS-SM. The main complication was postoperative fever (0.7%).
Postoperative fever in three patients with and hematuria and blood
clot retention in one were resolved by supportive treatments and
Foley catheterization with normal saline irrigation. Upward
migration of a double-J stent was found in one patient, and the
double-J stent was removed soon after the problemwas discovered.
There were no major complications such as ureteral perforation or
avulsion.Table 2
Success rates according to stone location.
Stone location (n) Success, n (%)
Upper ureter (n¼ 138) 122 (88.4%)
Middle ureter (n¼ 33) 32 (97.0%)
Lower ureter (n¼ 259) 259 (100.0%)
Multiple and steinstrasse (n¼ 8) 5 (62.5%)
Overall success rate (n¼ 438) 418 (95.4%)4. Discussion
4.1. ESWL versus URS for treatment of ureteral calculi
With regard to the minimally invasive management of ureteral
calculi, ESWL is considered a highly efﬁcacious, noninvasive,
anesthesia-free method for the majority of cases. The success rate
of ESWL is affected by several factors, such as the stone size, loca-
tion, and composition, lithotriptor type, surgeon’s experience,
secondary procedures applied, and particularly the retreatment
rate.2 Huang and colleagues3 compared the cost-effectiveness of
treating ureteral stones between ESWL and URS-SM in a Taipei City
hospital. On the one hand, ESWL for ureteral calculi usually ach-
ieved good results only at the expense of repeated treatments and
with the use of auxiliary procedures. On the other hand, post-ESWL
fragment expulsion was often accompanied by colic and other
urinary symptoms, sometimes lasting several days, which can
result in signiﬁcant discomfort to patients. In their study, ESWL had
higher medical costs than URS-SM.3 In 2007, the American
Urological Association and the European Association of Urology
(AUA/EAU) published guidelines for managing ureteral stones.4e6
The authors concluded that both ESWL and URS-SM are appro-
priate ﬁrst-line therapies in healthy, nonpregnant adults who have
unilateral ureteral calculi with no other stones that require treat-
ment, and who have normal contralateral renal function. There is
no difference in the rates of complications between these two
treatment modalities. A meta analysis of 244 studies demonstrated
that URS-SMwas associatedwith higher stone free rates than ESWL
for stones of all sizes, with the exception of proximal ureteral stones
of less than 1 cm, for which ESWL was slightly more effective than
URS-SM.5 AUA/EAU guidelines5 state that ESWL is the recom-
mended ﬁrst-line treatment for stones of  1 cm in the proximal
ureter, while the optimal treatment for stones of > 1 cm remains to
be determined with ESWL and URS both being acceptable options.
A single institution retrospective review of 5133 URS procedures
in 4512 patients with lower ureteral calculi demonstrated the
safety and efﬁcacy of this procedure, with a 94.6% stone free rate.7
Major intraoperative and postoperative complications were very
rare, with a ureteral avulsion rate of 0.35% and a ureteral stricture
rate of 0.23%.7 They also documented that improvements in URS
design, accessories, techniques, and experience had led to a signif-
icant increase in the success rate and a decrease in the complication
rate. Bapat and colleagues8 compared success rates and complica-
tions of URS with a pneumatic lithoclast and holmium laser litho-
tripsy in managing upper ureteral stones in 394 patients. They
concluded that fragmentation rates of holmium laser-assisted URS
were better in the upper ureter.8 In their opinion, laser lithotripsy
with a slender semirigid URS was the favored modality for
management of upper ureteral stones of < 2 cm in patients with
a short duration of symptoms.8
4.2. URS-SM for ureteral calculi in our experience
Our study of 438 URS-SM procedures in 420 patients revealed
an overall 95.4% clearance rate for ureteral stones. The clearance
rates of lower (259), middle (33), upper (138), and multiple (8)
Y.-C. Li et al. / Urological Science 23 (2012) 45e47 47ureteral stones were 100%, 97%, 88.4%, and 62.5%, respectively.
Upward stone migration in 4.6% patients was the only reason for
failure of the procedure. Kijvikai and colleagues4 noted that failure
of URS-SM in the proximal ureter was often associated with stone
migration into the renal pelvis and calices. The introduction of the
holmium laser, which is effective in fragmenting any kind of stone,
has tremendously increased the efﬁcacy of intracorporeal litho-
tripsy and has now become the most acceptedmodality of URS-SM.
The degree of retropulsion depends on the energy source used,
with electrohydraulic and pneumatic lithotriptors causing a greater
degree of retropulsion than do lasers.9 In our experience, a slender
semirigid ureteroscope (4.5 or 6 Fr) in combination with a low-
power holmium laser (800 mJ at 8 Hz) produced the best results.
Furthermore, various strategies and devices were developed to
prevent stone retropulsion during lithotripsy. For example, placing
patients in the reverse Trendelenburg positionwith lateral rotation,
decreasing the irrigant pressure and ﬂow rate, and initially hitting
the stone peripherally have all shown promising results. Several
stone occlusion devices such as the Stone Cone (Boston Scientiﬁc,
Natick, MA, USA) and NTrap (Cook Urological, Spencer, IN, USA)
were recently introduced to avoid stone retrograde migration and
assist in fragment extraction. We have tried to use the NTrap device
to entrap stones; however, the disintegrated stone fragments
jammed the wire mesh net of the device, hindering net retrieval
into the sheath after the procedure. We decided not to use this
device due to safety and durability considerations. In addition,
recent studies demonstrated the efﬁcacy of a novel thermosensitive
polymer (Backstop, Pluromed, Woburn, MA, USA) in preventing
stone retropulsion, which is not traumatic to the ureter.10
4.3. Double-J stenting after URS-SM
The placement of an indwelling ureteral stent after URS-SM is
required to relieve postoperative pain due to obstruction caused by
ureteral edema or stone fragments and promptly establish urinary
ﬂow from the kidneys to the bladder. In addition, stents may
facilitate fragment passage, allow dilation of the ureter for subse-
quent procedures if necessary, promote healing, and prevent
stricture formation.11 In consideration of the positive contribution
of stenting, we almost always use a ureteral stent (86.8%) or cath-
eter (7.5%) after the procedure unless stone fragments are removed
completely by the forceps or basket. According to the most recent
AUA/EAU guidelines,5 strong indications for stent placement are
suspected ureteral injury, ureteral stricture, a solitary kidney, renal
insufﬁciency, and a large residual stone burden. As a result, the
decision of whether or not to place a stent can only be made by the
surgeon at the time of the operation. In uncomplicated cases, it
seems that a ureteral stent might not be necessary.
4.4. Future of URS-SM
The introduction of ﬂexible URS has led to new dimensions in
diagnosing and treating upper urinary tract lesions, especially
urinary tract calculi. Krambeck and colleagues12 described amodern
series of URS-SM at the Mayo Clinic (Rochester, MN, USA) that
included over 350 ﬂexible URS procedures and 1000 patients. The
stone free rate of this procedure in the proximal ureter was 91.7%,
which is comparable with reported ESWL success rates. The overallcomplication rate in that series was 1.8%, with a 0.2% stricture rate.
Currently available ﬂexible URSs have thinner tips assisted by an
access sheath, which facilitates quick access into the ureter. The
durability of these devices continues to improve, as do the optics,
especially with the introduction of digital technology.13 However,
high costs for the purchase and repair of ﬂexible URS limit its clinical
role in our institution due to economic considerations. In the future,
innovative advances in technology and the durability of these
instruments and devices will likely provide excellent results in
managing upper urinary tract problems in a minimally invasive
fashion.5. Conclusion
Ureteroscopy is a highly effective, safe, and feasible treatment
modality for ureteral calculi, and it has demonstrated high success
rates and low complication rates. Our study results are similar to
those in the literature, which indicates that our accumulated
experiences have made us skilled at treating ureteral calculi using
this method. With continued advances, ﬂexible ureteroscopy
should play important roles in diagnosing and treating upper
urinary tract diseases.Conﬂicts of interest statement
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